全文获取类型
收费全文 | 854篇 |
免费 | 32篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 35篇 |
妇产科学 | 6篇 |
基础医学 | 99篇 |
口腔科学 | 21篇 |
临床医学 | 58篇 |
内科学 | 111篇 |
皮肤病学 | 8篇 |
神经病学 | 78篇 |
特种医学 | 26篇 |
外科学 | 194篇 |
综合类 | 6篇 |
预防医学 | 28篇 |
眼科学 | 7篇 |
药学 | 42篇 |
肿瘤学 | 161篇 |
出版年
2023年 | 2篇 |
2022年 | 15篇 |
2021年 | 33篇 |
2020年 | 12篇 |
2019年 | 15篇 |
2018年 | 30篇 |
2017年 | 14篇 |
2016年 | 15篇 |
2015年 | 15篇 |
2014年 | 48篇 |
2013年 | 45篇 |
2012年 | 63篇 |
2011年 | 69篇 |
2010年 | 29篇 |
2009年 | 24篇 |
2008年 | 42篇 |
2007年 | 47篇 |
2006年 | 31篇 |
2005年 | 33篇 |
2004年 | 36篇 |
2003年 | 42篇 |
2002年 | 32篇 |
2001年 | 22篇 |
2000年 | 34篇 |
1999年 | 28篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1979年 | 4篇 |
1974年 | 3篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1967年 | 2篇 |
1966年 | 4篇 |
1964年 | 1篇 |
1940年 | 1篇 |
1935年 | 1篇 |
排序方式: 共有887条查询结果,搜索用时 46 毫秒
1.
Marek Szolkiewicz Elzbieta Sucajtys Wojciech Wolyniec Przemyslaw Rutkowski Ewa Stelmanska Justyna Korczynska Julian Swierczynski Boleslaw Rutkowski 《Journal of renal nutrition》2005,15(1):166-172
OBJECTIVE: Hyperlipidemia is a permanent finding in advanced renal failure. It is supposed to be responsible for the accelerated arteriosclerosis and cardiovascular complications observed in patients with that disease. The background is partially determined, however, our knowledge in this matter is not yet satisfactory. METHODS: This study is based on the experimental rat model of chronic renal failure (CRF). Considering white adipose tissue (WAT) lipogenesis upregulation in CRF, along with the determination of acetyl coenzyme A carboxylase (ACC) and fatty acid synthase (FAS) genes expression, we have measured WAT gene expression for sterol regulatory binding protein 1 (SREBP-1) at the level of protein mass and mRNA abundance. Furthermore, we have determined glucose uptake, glucose-to-CO 2 conversion rate, and glucose translocator (GLUT-4) gene expression in WAT. RESULTS: Upregulation of both FAS and ACC gene expression was found in WAT of CRF rats. It was accompanied by WAT SREBP-1 gene overexpression. Moreover, we have observed the increased glucose uptake, glucose to CO 2 conversion rate, and GLUT-4 gene expression in WAT of CRF rats in comparison with controls. CONCLUSION: SREBP-1 gene overexpression may contribute to enhanced lipogenesis upregulation in WAT of CRF rats. It is not excluded that the increased WAT glucose metabolism activity is also induced by this mechanism, although there is no evidence currently to that end. We hypothesize that the increased WAT lipogenesis capacity could be a part of mechanism(s) leading to CRF-induced hyperlipidemia. 相似文献
2.
3.
The action of atriopeptin III on renal function in two models of chronic renal failure in the rat. 总被引:1,自引:1,他引:0 下载免费PDF全文
1. The natriuretic and diuretic effects of atriopeptin III (125, 250 and 500 ng kg-1, i.v.) were studied in groups of rats anaesthetized with pentobarbitone which were either sham controls, unilaterally nephrectomized controls, adenine-fed or subtotal nephrectomy chronic renal failure models. 2. Atriopeptin III given at these doses to the sham control animals had no effect on blood pressure, renal blood flow or glomerular filtration rate but reversibly increased urine flow, between 46% to 54%, absolute sodium excretion, between 52% to 61%, and fractional sodium excretion, between 48% to 54% (all P values less than 0.05) from the lowest to the highest dose. The adenine-fed chronic renal failure group of rats had a reduced renal blood flow of between 30 and 75%, and glomerular filtration rate of approximately 20%, compared to the sham controls. Administration of atriopeptin at 125, 250 and 500 ng kg-1 to the animals with renal failure increased water and sodium excretion to the same degree as observed in the sham group of rats. 3. In the group of unilaterally nephrectomized rats, atriopeptin III, at 125, 250 and 500 ng kg-1 increased urine flow by 36%, 47% and 72%, respectively, absolute sodium excretion by 37%, 57% and 106%, respectively, and fractional sodium excretion by 46%, 45% and 102%, respectively. A similar pattern of responses was observed in the subtotal nephrectomy, chronic renal failure group in which filtration rate was approximately 4 times less than the controls.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
4.
Boleslaw RUTKOWSKI Marek SZOLKIEWICZ Jacek MANITIUS Jolanta MYLAWSKA Ewa BRYL Andrzej MYSALIWSKI 《Nephrology (Carlton, Vic.)》1997,3(5):323-327
Summary: In this study, the administration of erythropoietin to haemodialysis patients revealed its immunomodulating properties. to dissociate the immunological effects of erythropoietin action from its haematological effects the patients in our study were administered recombinant human erythropoietin (rhEpo) at the doses that would not affect erythropoiesis. After baseline data had been obtained, six haemodialysis patients were given rhEpo (Eprex-Cilag) at the dose 7-10 U/kg bodyweight/s.c., three times a week, for 12 weeks. All patients maintained a stable haemoglobin concentration; no blood transfusions were required. Serum levels of tumour necrosis factor (TNF), IL-2 and IL-6 levels of the study patients and the four control patients, not receiving rhEpo, were monitored every 2 weeks. the levels of IL-6 and TNF remained unchanged; however, a low serum level of IL-2, recorded before therapy, increased gradually for 10 weeks until it reached the values observed in normal healthy humans (P<0.01). After that it dropped to the initial values. During the study the red blood cell numbers did not change. This study supports the thesis that erythropoietin administered to haemodialysis patients not only corrects anaemia but also independently modulates immunological response. 相似文献
5.
Treatment of End-Stage Renal Disease in Central and Eastern Europe: Overview of Current Status and Future Needs 总被引:2,自引:0,他引:2
Bolesaw Rutkowski Aleksandru Ciocalteu Ljubica Djukanovic Istvan Kiss Aleksander Kovac Momir Polenakovic Zvonimir Puretic Rafail Rozental Maria Stanaityte Irina Tareyeva Vladimir Teplan Jeff Zavitz Krivoshiev Stefan & Kveder Rado 《Artificial organs》1998,22(3):187-191
The situation of end-stage renal disease (ESRD) patients in central and eastern Europe was very poor for many years during the so called socialistic era. Economical and political liberation resulted in the significant growth of renal replacement facilities in this region. The number of hemodialysis units increased significantly (56%) during the period 1990–1996, and the number of patients treated with this modality has risen by 75%. More dramatic progress was achieved in peritoneal dialysis. The number of units performing this method of renal replacement therapy (RTT) increased by 277% and the number of patients by more than 300%. Not only quantitative but also qualitative changes were observed. More modern hemodialysis machines installed in the vast majority of units allow for the performance of bicarbonate dialysis, controlled ultrafiltration, and sodium profile modeling. Also, a wider choice of biocompatible dialyzers has become available during the last few years. The number of centers performing renal transplantation has increased significantly, but the number of renal transplants has not followed this progress. Despite all the progress, further development of all RRT methods is necessary to achieve acceptance rates comparable to those observed in developed countries. 相似文献
6.
Douglas A. Weeks Richelle L. Malott Craig W. Zuppan Boleslaw H. Liwnicz J. Bruce Beckwith 《Ultrastructural pathology》1994,18(1):23-28
The rhabdoid tumor (RT) was first described as an aggressive neoplasm of unknown histogenesis affecting the kidneys of infants and young children, but has since been reported in all ages and in many other primary sites, including the central nervous system. It has been shown, however, that the histologic and cytologic features of RT can be mimicked by many other tumors of known histogenesis. For this and other reasons it remains controversial whether cases of putative extrarenal RT represent the same histogenetic entity as RT of the kidney (RTK), another entity or entities, or merely a diverse collection of unrelated tumors sharing a common morphologic phenotype. The present paper describes a lethal primary cerebral tumor in a 26-month-old Hispanic boy that was composed predominantly of cells exhibiting the “classic” rhabdoid phenotype by light microscopy. lmmunocytochemical and ultrastructural studies disclosed features of primitive neuroglial differentiation not seen in RTK. The findings in this case, as well as evidence from other studies, would seem to support the notion that primary RT of the brain may in fact constitute a morphologic and clinicopathologic entity. However, hat entity likely represents a distinctive type of neuroglial neoplasm, more closely related t o other primitive brain tumors than t o RTK. 相似文献
7.
Rutkowski R Moniuszko T Stasiak-Barmuta A Kosztyła-Hojna B Alifier M Rutkowski K Tatarczuk-Krawiel A 《Archivum immunologiae et therapiae experimentalis》2003,51(6):421-428
CD80 and CD86 seem to play an important role in the allergen-induced secretion of interleukin (IL)-5 and IL-13. Up to now, the expressions of CD80 (B7.1) and CD86 (B7.2) on monocytes and the kinetics of the expression of these molecules on lipopolysaccharide-stimulated monocytes in nonatopic asthma have not been defined. Using monoclonal antibodies, we have compared the expressions of CD80 (B7.1) and CD86 (B7.2) on the monocytes of healthy persons and nonatopic asthmatic patients. We have also assessed the effect of CD80 and CD86 inactivation on IL-4 and interferon (IFN)-gamma production in nonatopic asthmatics and healthy subjects. We found that a low expression of CD80 (1.64 +/- 0.65 vs. 3.53 +/- 1.43%) and a moderate expression of CD86 (41.25 +/- 13.4 vs. 49.46 +/- 11.49%) on the studied monocytes were characteristic for asthma. In nonatopic asthma patients inactivation of CD80 or CD86 blockade significantly reduced IFN-gamma production by T lymphocytes (p < 0.02; p < 0.03). In both the studied groups, anti-CD80 antibodies did not diminish T lymphocyte production of IL-4. However, anti-CD86 antibodies significantly (p < 0.04) reduced the IL-4 concentration in culture supernatants. Our results confirm that both the CD80 and CD86 molecules play an important role in the maintenance and amplification of the inflammatory process. It suggests that in the inflammatory process that occurs in nonatopic bronchial asthma, Th1 as well as Th2 lymphocytes are equally important. 相似文献
8.
Lim DJ Rubenstein AE Evans DG Jacks T Seizinger BG Baser ME Beebe D Brackmann DE Chiocca EA Fehon RG Giovannini M Glazer R Gusella JF Gutmann DH Korf B Lieberman F Martuza R McClatchey AI Parry DM Pulst SM Ramesh V Ramsey WJ Ratner N Rutkowski JL Ruttledge M Weinstein DE 《Journal of neurogenetics》2000,14(2):63-106
9.
10.
Adam Brewczyski Beata Jaboska Sawomir Mrowiec Krzysztof Skadowski Tomasz Rutkowski 《Nutrients》2021,13(1)
Malnutrition is a common problem in patients with head and neck cancer (HNC), including oropharyngeal cancer (OPC). It is caused by insufficient food intake due to dysphagia, odynophagia, and a lack of appetite caused by the tumor. It is also secondary to the oncological treatment of the basic disease, such as radiotherapy (RT) and chemoradiotherapy (CRT), as a consequence of mucositis with the dry mouth, loss of taste, and dysphagia. The severe dysphagia leads to a definitive total impossibility of eating through the mouth in 20–30% of patients. These patients usually require enteral nutritional support. Feeding tubes are a commonly used nutritional intervention during radiotherapy, most frequently percutaneous gastrostomy tube. Recently, a novel HPV-related type of OPC has been described. Patients with HPV-associated OPC are different from the HPV− ones. Typical HPV− OPC is associated with smoking and alcohol abuse. Patients with HPV+ OPC are younger and healthy (without comorbidities) at diagnosis compared to HPV− ones. Patients with OPC are at high nutritional risk, and therefore, they require nutritional support in order to improve the treatment results and quality of life. Some authors noted the high incidence of critical weight loss (CWL) in patients with HPV-related OPC. Other authors have observed the increased acute toxicities during oncological treatment in HPV+ OPC patients compared to HPV− ones. The aim of this paper is to review and discuss the indications for nutritional support and the kinds of nutrition, including immunonutrition (IN), in HNC, particularly OPC patients, undergoing RT/CRT, considering HPV status. 相似文献